How to (legally) make psychedelic medicine: CEO of Psygen, Danny Motyka
Business Trip
English - February 24, 2021 16:00 - 30 minutes - 21.3 MBEntrepreneurship Business Health & Fitness Mental Health psychedelics psychedelic psychedelic startups mental health wellness human flourishing Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Today's episode features Danny Motyka, founder of Psygen, a Canadian manufacturer of psychedelics, like MDMA, LSD, DMT, and synthetic psilocybin.
Psygen makes pharmaceutical grade psychedelic medicines for clinical research and therapeutic applications. They have a license to be one of the first manufacturing facilities dedicated to the synthesis of psychedelic medicine.
In this episode, we discuss:
Behind the scenes of Psygen’s manufacturing processNatural vs Synthetic psychedelicsNavigating regulations for manufacturing Schedule 1 substancesLinks to topics discussed in this episode:
GMP
Dr. Peter van der Heyden
COMP360
Entourage Effect
Health Canada
Nick Sand - Orange Sunshine
MDMA, LSD, 5-MeO-DMT, Ibogaine, Psilocybin
Entheon Biomedical
MAPS
2C-B
Read the transcript here.
Watch episode 6 on YouTube.
Created by Greg Kubin and Matias Serebrinsky
Host: Greg Kubin
Produced by Jonathan A. Davis & Zack Frank
Marketing by DaisyMae VanValkenburgh
Find us at businesstrip.fm
Follow us on Instagram and Twitter!
Theme music by Dorian Love
Additional music by Crystals by Xylo-Ziko, Obscure Train by Revolution Void, Love Chances by Makaih Beats, and Kleptotonic Swing by Tri-Tachyon